In conclusion, to the best of our knowledge, the present study reports for the first time a population of immunosuppressive monocytes, characterized by the CD14+HLA-DRlow/− phenotype, which were significantly elevated in CLL patients and were poor predictors of survival in CLL patients (n=49). Here, CD14 is linked to B-cell chronic lymphocytic leukemia.